BIOPSY-PROVEN HISTOLOGIC SCORES

Clinical trials for BIOPSY-PROVEN HISTOLOGIC SCORES explained in plain language.

Never miss a new study

Get alerted when new BIOPSY-PROVEN HISTOLOGIC SCORES trials appear

Sign up with your email to follow new studies for BIOPSY-PROVEN HISTOLOGIC SCORES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial aims to stop kidney transplant rejection

Disease control Recruiting now

This study is testing whether an experimental drug called ALXN2030 can help control antibody-mediated rejection in adults who have received kidney transplants. About 45 participants will receive either one of two doses of ALXN2030 or a placebo for 52 weeks, along with their stand…

Matched conditions: BIOPSY-PROVEN HISTOLOGIC SCORES

Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

BIOPSY-PROVEN HISTOLOGIC SCORES

Get alerted when new BIOPSY-PROVEN HISTOLOGIC SCORES trials appear

New drug trial aims to stop kidney transplant rejection